Alfred E. Mann Found. For Scientific Research v. Cochlear Corp.
Decision Date | 14 May 2010 |
Docket Number | No. 2009-1447.,2009-1447. |
Parties | ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH, Plaintiff-Appellant,v.COCHLEAR CORPORATION and Cochlear Ltd., Defendants-Appellees. |
Court | U.S. Court of Appeals — Federal Circuit |
COPYRIGHT MATERIAL OMITTED
Brian G. Bodine, Lane Powell PC, of Seattle, WA, argued for plaintiff-appellant. With him on the brief were Peter Gergely, Merchant & Gould P.C. of Denver, CO; and Malcolm J. Romano, Alfred E. Mann Foundation for Scientific Research, of Santa Clarita, CA.
Bruce G. Chapman, Connolly Bove Lodge & Hutz LLP, of Los Angeles, CA, argued for defendants-appellees. With him on the brief were Manuel C. Nelson and Keith D. Fraser.
Before MICHEL, Chief Judge, NEWMAN, and DYK, Circuit Judges.
The Alfred E. Mann Foundation for Scientific Research (“AMF”) is a research organization interested in developing new medical technologies, including cochlear implants. Cochlear Corporation and Cochlear Ltd. (collectively, “Cochlear”) are companies that build cochlear implants for use in human patients. AMF sued Cochlear for patent infringement, and the district court dismissed the case for lack of standing to sue. At issue is a 2004 agreement between AMF and Advanced Bionics (“AB”), another company that builds cochlear implants, granting AB an exclusive license to the patents that AMF later accused Cochlear of infringing. Cochlear contends, and the district court held, that this agreement was a virtual assignment of the patents-in-suit to AB, giving AB the sole right to sue for infringement of those patents. We find that AMF is the owner of the patents-in-suit because it retained substantial rights in the patents, including the right to sue for infringement if AB declines to do so. Accordingly, we reverse the district court's holding that AMF lacked standing to sue, and we remand for proceedings consistent with this opinion.
In the mid-1980s, Alfred E. Mann, an inventor of medical devices, founded AMF to develop new medical technologies. AMF conducts research aimed at developing implantable medical devices that can improve health, safety, and quality of life. Among these technologies are cochlear implants, devices that are placed in the inner ear to allow profoundly deaf or severely hard-of-hearing patients to regain their ability to hear. Cochlear implants are sometimes referred to as “bionic ears.” The patents-in-suit, U.S. Patent No. 5,609,616 (“the '616 patent”) and U.S. Patent No. 5,938,691 (“the '691 patent”), disclose and claim cochlear implants and related technologies used to improve hearing. These patents were issued to researchers at AMF, and those researchers assigned the patents to AMF.
As a source of funding for its research work, AMF licenses its patents to for-profit companies that build medical devices. Here, the '616 patent and the '691 patent were licensed to AB under a license agreement entered into in 2004. The license agreement granted AB the following rights:
In addition, AMF retained several rights and obligations under the license agreement:
In litigation commenced by either party, the other party to the agreement maintained the right (but not the obligation) to participate in the litigation by hiring its own counsel and by requiring the litigation-commencing party to keep it informed about the status of the litigation, but the non-commencing party was not permitted to interfere with the commencing party's control of the litigation in any way.
After this license agreement was entered into, AMF notified AB of Cochlear's allegedly infringing activity and sought to determine AB's decision regarding whether to sue Cochlear for infringement of the '616 patent. Having received assurance that AB did not plan to sue over this alleged infringement, AMF filed suit in December 2007. Eventually, the pleadings were amended to allege infringement of both the '616 patent and the '691 patent.
During discovery in the district court, Cochlear learned of the 2004 license agreement between AMF and AB. On March 3, 2009, Cochlear filed a motion to dismiss AMF's infringement claims for lack of standing to sue. On May 29, 2009, the district court granted the motion, finding that, because AMF had transferred to AB “all substantial rights under the patents,” AB should be “considered the owner of those patents.” On June 19, 2009, the district court entered judgment dismissing the case, and AMF appealed to this court on June 23, 2009.
We review de novo the district court's decisions regarding standing to sue. Rite-Hite Corp. v. Kelley Co., 56 F.3d 1538, 1551 (Fed.Cir.1995) (en banc). A patent owner may transfer all substantial rights in the patents-in-suit, in which case the transfer is tantamount to an assignment of those patents to the exclusive licensee, conferring standing to sue solely on the licensee. Vaupel Textilmaschinen KG v. Meccanica Euro Italia SpA, 944 F.2d 870, 873-74 (Fed.Cir.1991). To determine whether an exclusive license is tantamount to an assignment, we “must ascertain the intention of the parties [to the license agreement] and examine the substance of what was granted.” Mentor H/S, Inc. v. Medical Device Alliance, Inc., 240 F.3d 1016, 1017 (Fed.Cir.2001). Here, the license agreement is to be interpreted under California law, under which the district court's interpretation of a contract presents a question of law that we review de novo. DVD Copy Control Ass'n v. Kaleidescape, Inc., 176 Cal.App.4th 697, 713, 97 Cal.Rptr.3d 856, 869 (Cal.App. 6th Dist.2009). To the extent that determining the intention of the parties to the license agreement requires evaluation of parol evidence, the district court's evaluation presents a question of fact that we review deferentially. Id.
As noted above, a patent owner may grant an exclusive license to his patents under such terms that the license is tantamount to an assignment of the patents to the exclusive licensee. This happens when the exclusive license transfers “all substantial rights” in the patents. Vaupel Textilmaschinen, 944 F.2d at 873-74. When this happens, the exclusive licensee has sole standing to sue those suspected of infringing the patents' claims. Id. In addition, we have held that, where an exclusive license transfers less than “all substantial rights” in the patents to the exclusive licensee, the exclusive licensee may still be permitted to bring suit against infringers, but the patent owner is an indispensable party who must be joined. Prima Tek II, L.L.C. v. A-Roo Co., 222 F.3d 1372, 1377 (Fed.Cir.2000). Typically, we are confronted with cases in which an exclusive licensee sues an accused infringer, and we must decide whether the licensee has been granted rights sufficient to confer standing. This case presents a converse scenario in which the patent owner seeks to bring suit, requiring us to determine whether the patent owner transferred away sufficient rights to divest it of any right to sue.
We were faced with a similar set of facts in Aspex Eyewear, Inc. v. Miracle Optics, Inc., 434 F.3d 1336 (Fed.Cir.2006). There, the patent owner, Contour Optik, Inc., had granted an exclusive license to Chic Optic, Inc., which was not a party to the infringement litigation. Id. at 1338. In turn, Chic Optic assigned its rights to Aspex Eyewear. Id. Shortly before the grant of rights from Chic Optic to Aspex Eyewear, Contour Optik and Aspex Eyewear jointly sued Miracle Optics for infringement. Id. We held that, because the grant from Contour Optik to Chic Optic was a grant of less than all substantial rights, Contour remained the owner of the patents-in-suit and retained standing to sue for infringement. Id. at 1343.
Under Aspex Eyewear, a patent may not have multiple separate owners for purposes of determining standing to sue.2 Either the licensor did not...
To continue reading
Request your trial-
Immunex Corp. v. Sandoz Inc.
...of the parties [to the license agreement] and examine the substance of what was granted.’ " Alfred E. Mann Found. For Sci. Research v. Cochlear Corp. , 604 F.3d 1354, 1359 (Fed. Cir. 2010) (quoting Mentor H/S, Inc. v. Med. Device All., Inc. , 240 F.3d 1016, 1017 (Fed. Cir. 2001) ); see also......
-
Univ. of Utah v. Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V.
...that a “patent owner is an indispensable party who must be joined.” Appellant's Br. 43 (quoting Alfred E. Mann Found. For Sci. Research v. Cochlear Corp., 604 F.3d 1354, 1359 (Fed.Cir.2010)). But these cases deal with standing to bring suit, not with indispensability under Rule 19(b). See A......
-
W.L. Gore & Assocs., Inc. v. C.R. Bard, Inc.
...of the patent, and that individual is permitted to sue for infringement in his own name." Alfred E. Mann Found. For Scientific Research v. Cochlear Corp. , 604 F.3d 1354, 1360 (Fed.Cir.2010). Thus, if a patentee transfers "all substantial rights " in the patent to an assignee, "this amounts......
-
Delano Farms Co. v. the Cal. Table Grape Comm'n
...licensee the right to enforce the patent and divests the licensor of that same right. E.g., Alfred E. Mann Found. for Scientific Research v. Cochlear Corp., 604 F.3d 1354, 1361 (Fed.Cir.2010) (describing the scope of the licensee's right to sue infringers as often “the most important consid......
-
International Trade Commission Clarifies The Requirements For Standing In A Patent Infringement Investigation At The ITC
...does not hold all substantial rights in the Wild Patents or Kadlec Patents."). Id. at 17. 473 F.3d 1187, 1191-92 (Fed. Cir. 2007). 604 F.3d 1354, 1362 (Fed. Cir. 2010). Inv. No. 337-TA-818, Order No. 15 at 3 (July 18, 2012). Certain Optical Disc Drives at 20. Id. at 26. Id. at 24. Id. at 25......
-
Patent And Trademark Bulletin For The District Of Massachusetts - July 2013
...to PerkinElmer, the Court reviewed the nine factor test set forth in Alfred E. Mann Found. For Scientific Research v. Cochlear Corp., 604 F.3d 1354, 1360-61 (Fed. Cir. 2010). According to that case, "the nature and scope of the licensor's retained right to sue accused infringers is the most......
-
A Patent Perspective on Autonomous Vehicles
...12,114 in 2016 to 11,418 in 2017. AUTM Survey, supra note 2, at 8. 14. See Alfred E. Mann Found. for Sci. Research v. Cochlear Corp., 604 F.3d 1354, 1358–59 (Fed. Cir. 2010) (“A patent owner may transfer all substantial rights in the patents-in-suit, in which case the transfer is tantamount......
-
Machines of Ordinary Skill in the Art: How Inventive Machines Will Change Obviousness
...12,114 in 2016 to 11,418 in 2017. AUTM Survey, supra note 2, at 8. 14. See Alfred E. Mann Found. for Sci. Research v. Cochlear Corp., 604 F.3d 1354, 1358–59 (Fed. Cir. 2010) (“A patent owner may transfer all substantial rights in the patents-in-suit, in which case the transfer is tantamount......
-
Keep an Eye on the Issue of Sovereign Immunity When Licensing State University-Based Patent Rights in Light of Ericsson Inc. v. Regents of the University of Minnesota
...12,114 in 2016 to 11,418 in 2017. AUTM Survey, supra note 2, at 8. 14. See Alfred E. Mann Found. for Sci. Research v. Cochlear Corp., 604 F.3d 1354, 1358–59 (Fed. Cir. 2010) (“A patent owner may transfer all substantial rights in the patents-in-suit, in which case the transfer is tantamount......